26 enregistrements « 1 de 3 »

Kampmann B, Madhi SA, Munjal I, Simões EAF, Pahud BA, Llapur C, Baker J, Pérez Marc G, Radley D, Shittu E, Glanternik J, Snaggs H, Baber J, Zachariah P, Barnabas SL, Fausett M, Adam T, Perreras N, Van Houten MA, Kantele A, Huang LM, Bont LJ, Otsuki T, Vargas SL, Gullam J, Tapiero B, Stein RT, Polack FP, Zar HJ, Staerke NB, Duron Padilla M, Richmond PC, Koury K, Schneider K, Kalinina EV, Cooper D, Jansen KU, Anderson AS, Swanson KA, Gruber WC, Gurtman A,

Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants

Article de revue

N Engl J Med, 388 (16), 2023.

Résumé | Liens:

Marathe G, Moodie EEM, Brouillette MJ, Lanièce Delaunay C, Cox J, Martel-Laferrière V, Gill J, Cooper C, Pick N, Vachon ML, Vachon ML, Walmsley S, Klein MB,

Impact of Hepatitis C Virus Cure on Depressive Symptoms in the Human Immunodeficiency Virus-Hepatitis C Virus Coinfected Population in Canada

Article de revue

Clin Infect Dis, 76 (3), 2023.

Résumé | Liens:

Marathe G, Moodie EEM, Brouillette MJ, Cox J, Cooper C, Delaunay CL, Conway B, Hull M, Martel-Laferrière V, Vachon ML, Walmsley S, Wong A, Klein MB,

Predicting the presence of depressive symptoms in the HIV-HCV co-infected population in Canada using supervised machine learning

Article de revue

BMC Med Res Methodol, 22 (1), 2022.

Résumé | Liens:

Pedersen J, Moukandja IP, Ndidi S, Sørensen AL, Koumakpayi IH, Lekana-Douki JB, Vachon ML, Weis N, Kobinger G, Fausther-Bovendo H

An adaptable platform for in-house hepatitis C serology

Article de revue

J Virol Methods, 308 , 2022.

Résumé | Liens:

Manion M, Lynn N, Pei L, Hammoud DA, Laidlaw E, Roby G, Metzger D, Mejia Y, Lisco A, Zelazny A, Holland S, Vachon ML, Scherer M, Bergin C, Sereti I

To Induce Immune Reconstitution Inflammatory Syndrome or Suppress It: The Spectrum of Mycobacterium genavense in the Antiretroviral Era

Article de revue

Clin Infect Dis, 72 (2), 2021.

Résumé | Liens:

Onofrio FQ, Cooper C, Borgia SM, Vachon ML, Ramji A, Lilly LB, Wong A, Booth J, Sattar I, Morales H, Lee S, Conway B, Feld JJ

Salvage Therapy with Sofosbuvir/Velpatasvir/Voxilaprevir in DAA-experienced Patients: Results from a Prospective Canadian Registry

Article de revue

Clin Infect Dis, 72 (11), 2021.

Résumé | Liens:

Driedger M, Vachon ML, Wong A, Conway B, Ramji A, Borgia S, Tam E, Barrett L, Smyth D, Feld JJ, Lee SS, Cooper C

Direct-acting antiviral treatment uptake and sustained virological response outcomes are not affected by alcohol use: A CANUHC analysis

Article de revue

Can Liver J, 4 (3), 2021.

Résumé | Liens:

Cooper CL, Read D, Vachon ML, Conway B, Wong A, Ramji A, Borgia S, Tam E, Barrett L, Smyth D, Feld JJ, Lee S,

Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants

Article de revue

BMC Public Health, 20 (1), 2020.

Résumé | Liens:

Saeed S, Strumpf E, Moodie EEM, Wong L, Cox J, Walmsley S, Tyndall M, Cooper C, Conway B, Hull M, Martel-Laferriere V, Gill J, Wong A, Vachon ML, Klein MB,

Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living With Human Immunodeficiency Virus

Article de revue

Clin Infect Dis, 71 (2), 2020.

Résumé | Liens:

Murphy DG, Dion R, Simard M, Vachon ML, Martel-Laferrière V, Serhir B, Longtin J

Molecular surveillance of hepatitis C virus genotypes identifies the emergence of a genotype 4d lineage among men in Quebec, 2001-2017

Article de revue

Can Commun Dis Rep, 45 (9), 2019.

Résumé | Liens:

26 enregistrements « 1 de 3 »
Signaler des ajouts ou des modifications

Projets actifs

  • A Phase 2,Multicenter,Randomized,Double-Blind,Placebo-controlled Study to Evaluate Efficacy,Safety,Tolerability,and Pharmacokinetics of Budigalimab and/or ABBV-382 in People Living with HIV on Stable Antiretroviral [...], du 2024-03-28 au 2029-12-25
  • A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living with HIV, du 2022-10-01 au 2027-09-30
  • Optimiser le dépistage des populations vulnérables par goutte de sang séché, du 2022-01-15 au 2024-10-15
  • Surveillance des réponses immunitaires au vaccin contre la COVID-19 chez les personnes vivant avec le VIH-1, du 2021-12-01 au 2025-03-31

Projets terminés récemment

  • After the Cure: Measuring the full impacts of direct acting antivirals for people living with HIV/hepatitis C virus coinfection in Canada, du 2022-10-01 au 2023-03-31
  • Optimization of a live microneutralization assay to evaluate antibody levels against mpox in vaccinated or infected individuals in Quebec, du 2023-04-24 au 2024-04-23
Information provenant du registre des projets de recherche de l'Université Laval